Your browser is no longer supported. Please, upgrade your browser.
Settings
OVAS OvaScience, Inc. daily Stock Chart
OVAS [NASD]
OvaScience, Inc.
Index- P/E- EPS (ttm)-2.59 Insider Own0.80% Shs Outstand35.44M Perf Week18.75%
Market Cap67.34M Forward P/E- EPS next Y-1.31 Insider Trans0.00% Shs Float32.36M Perf Month22.58%
Income-82.30M PEG- EPS next Q-0.43 Inst Own63.00% Short Float14.31% Perf Quarter35.71%
Sales0.70M P/S96.19 EPS this Y5.30% Inst Trans-33.16% Short Ratio3.79 Perf Half Y-76.07%
Book/sh3.04 P/B0.62 EPS next Y15.50% ROA-60.30% Target Price1.00 Perf Year-80.43%
Cash/sh3.23 P/C0.59 EPS next 5Y- ROE-66.70% 52W Range1.30 - 11.66 Perf YTD24.18%
Dividend- P/FCF- EPS past 5Y3.10% ROI-75.10% 52W High-83.70% Beta3.55
Dividend %- Quick Ratio8.80 Sales past 5Y- Gross Margin- 52W Low46.15% ATR0.13
Employees118 Current Ratio8.80 Sales Q/Q-50.00% Oper. Margin- RSI (14)72.28 Volatility10.94% 7.98%
OptionableYes Debt/Eq0.00 EPS Q/Q15.90% Profit Margin- Rel Volume1.24 Prev Close1.91
ShortableYes LT Debt/Eq0.00 EarningsMar 02 AMC Payout- Avg Volume1.22M Price1.90
Recom3.00 SMA2022.23% SMA5022.38% SMA200-54.59% Volume1,509,676 Change-0.52%
Jan-25-16Downgrade Oppenheimer Outperform → Perform
Jan-21-16Initiated Credit Suisse Underperform
Nov-09-15Downgrade Leerink Partners Outperform → Mkt Perform
Oct-21-15Reiterated Oppenheimer Outperform $12 → $16
Sep-30-15Reiterated Oppenheimer Outperform $60 → $12
Sep-29-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-29-15Initiated JP Morgan Neutral $40
Jan-21-15Reiterated Oppenheimer Outperform $55 → $60
Dec-24-14Upgrade Oppenheimer Perform → Outperform
Dec-18-14Reiterated H.C. Wainwright Buy $40 → $100
Nov-11-14Reiterated H.C. Wainwright Buy $16 → $40
Oct-08-14Downgrade Oppenheimer Outperform → Perform $11
Apr-29-14Initiated Oppenheimer Outperform $11
Mar-28-17 12:07PM  SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In OvaScience, Inc. To Contact The Firm GlobeNewswire
Mar-27-17 10:42PM  Lifshitz & Miller LLP Files Class Action Lawsuit against OvaScience, Inc. PR Newswire +11.70%
04:02PM  ETFs with exposure to OvaScience, Inc. : March 27, 2017
Mar-24-17 06:50AM  OvaScience (OVAS) Shares March Higher, Can It Continue?
Mar-23-17 09:30AM  Biocept and OvaScience Post Gains Amid Investor Speculation Accesswire
08:20AM  OvaScience, Inc. (OVAS) Looks Good: Stock Up 9.6% Higher
Mar-21-17 11:35AM  OvaScience, Inc. :OVAS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
Mar-15-17 01:59PM  OvaScience, Inc. :OVAS-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
Mar-08-17 01:04PM  OVASCIENCE, INC. Financials
Mar-02-17 04:30PM  OvaScience Inc Earnings Call scheduled for 4:30 pm ET today
04:23PM  OVASCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:18PM  OvaScience reports 4Q loss
04:06PM  OvaScience Reports Fourth Quarter and Year-End 2016 Financial Results Business Wire
07:07AM  Q4 2016 OvaScience Inc Earnings Release - After Market Close
Feb-27-17 04:01PM  OvaScience to Present at Upcoming Investor Conferences in March Business Wire
Feb-23-17 04:01PM  OvaScience to Host Fourth Quarter and Fiscal Year 2016 Financial Results Conference Call Business Wire
Feb-17-17 05:11PM  Lifshitz & Miller LLP Announces Investigation of BT Group plc, Celadon Group, Inc., Community Health Systems, Inc., Dimension Therapeutics, Inc., Home Capital Group Inc., Lifevantage Corporation, OvaScience, Inc. and Under Armour, Inc. PR Newswire
Feb-15-17 03:03PM  5 Ways Allergan Can Keep Up Momentum
Feb-14-17 12:57PM  Newman Ferrara LLP Announces Corporate Governance Investigation of OvaScience, Inc. Business Wire
Jan-13-17 02:00PM  Troubled fertility biotech OvaScience offers CFO cash bonus not to leave at bizjournals.com
Jan-10-17 06:03AM  OVASCIENCE, INC. Files SEC form 8-K, Regulation FD Disclosure
Jan-05-17 04:02PM  OvaScience to Present at the 35th Annual J.P. Morgan Healthcare Conference Business Wire -6.29%
Dec-27-16 07:18AM  Implied Volatility Surging for OvaScience (OVAS) Stock Options
Dec-23-16 05:01PM  OVASCIENCE, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or Princi
04:05PM  OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Dec-22-16 04:04PM  Abercrombie, OvaScience Slide Into Thursdays 52-Week Low Club at 24/7 Wall St. -54.88%
06:25AM  Fertility-focused biotech OvaScience cuts 30% of workforce, new CEO resigns at bizjournals.com
Dec-21-16 04:55PM  OvaScience loses almost a third of its value amid massive layoffs, changes at MarketWatch
04:04PM  OvaScience Announces Business Update Business Wire
Dec-13-16 01:19PM  ETFs with exposure to OvaScience, Inc. : December 13, 2016
03:45AM  Is Agilysys, Inc. (AGYS) a Good Stock to Buy? at Insider Monkey
Dec-07-16 11:13AM  OvaScience Inc (OVAS): Hedge Fund Sentiment Flatlines at Insider Monkey -9.34%
Dec-02-16 12:59PM  ETFs with exposure to OvaScience, Inc. : December 2, 2016
Nov-30-16 08:55AM  Can OvaScience (OVAS) Keep the Earnings Streak Alive This Quarter?
Nov-23-16 02:08PM  Edited Transcript of OVAS earnings conference call or presentation 3-Nov-16 8:30pm GMT
Nov-21-16 08:38AM  OvaScience (OVAS) Enters Oversold Territory
Nov-11-16 01:26PM  These 5 Stocks Under $10 Could Make You a Lot of Money
Nov-10-16 12:50PM  ETFs with exposure to OvaScience, Inc. : November 10, 2016
Nov-08-16 10:48AM  OvaScience, Inc. :OVAS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016 -8.31%
Nov-03-16 05:13PM  OvaScience reports 3Q loss -6.80%
04:30PM  OvaScience Inc Earnings Call scheduled for 4:30 pm ET today
04:09PM  OVASCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  OvaScience Reports Third Quarter 2016 Financial Results Business Wire
07:07AM  Q3 2016 OvaScience Inc Earnings Release - After Market Close
Oct-31-16 04:02PM  OvaScience to Present at the 25th Annual Credit Suisse Healthcare Conference Business Wire
Oct-27-16 04:01PM  OvaScience to Host Third Quarter 2016 Financial Results Conference Call Business Wire -5.72%
Oct-12-16 02:33PM  Rebound May Be in Store for Beaten-Down Shares of TherapeuticsMD
Sep-27-16 10:13AM  ETFs with exposure to OvaScience, Inc. : September 27, 2016
Sep-20-16 08:58AM  OvaScience (OVAS) Shares March Higher, Can It Continue?
Sep-15-16 10:27AM  ETFs with exposure to OvaScience, Inc. : September 15, 2016
Sep-14-16 04:05PM  OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Sep-06-16 05:01PM  OVASCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
04:05PM  OvaScience Announces Executive Management Changes and Appointments to Further Drive Companys Growth Business Wire
Aug-31-16 08:30AM  OvaScience to Present at Upcoming Investor Conferences in September Business Wire
Aug-29-16 06:00AM  OvaSciences AUGMENT Treatment Commercially Available in Japan Through Partnership with IVF JAPAN GROUP Business Wire +6.49%
Aug-26-16 10:39AM  ETFs with exposure to OvaScience, Inc. : August 26, 2016
Aug-15-16 10:41AM  ETFs with exposure to OvaScience, Inc. : August 15, 2016
10:20AM  Edited Transcript of OVAS earnings conference call or presentation 4-Aug-16 8:30pm GMT
Aug-12-16 12:56PM  OvaScience, Inc. :OVAS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
Aug-11-16 02:31AM  Can The Uptrend Continue for OvaScience (OVAS)?
Aug-04-16 05:29PM  OvaScience reports 2Q loss
04:30PM  OvaScience Inc Earnings Call scheduled for 4:30 pm ET today
04:15PM  OVASCIENCE, INC. Files SEC form 10-Q, Quarterly Report
04:07PM  OVASCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:01PM  OvaScience Reports Second Quarter 2016 Financial Results Business Wire
07:07AM  Q2 2016 OvaScience Inc Earnings Release - After Market Close
Jul-28-16 04:05PM  OvaScience to Host Second Quarter 2016 Financial Results Conference Call Business Wire -5.66%
Jul-01-16 08:19AM  OVASCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +7.10%
07:00AM  Harald Stock, Ph.D. Commences Role as President and Chief Executive Officer of OvaScience Business Wire
Jun-17-16 08:00AM  OvaScience to Present at the JMP Securities Life Sciences Conference Business Wire
Jun-03-16 04:21PM  OVASCIENCE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -5.42%
04:05PM  OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire
Jun-01-16 04:05PM  OvaScience Announces Closing of Public Offering of Common Stock Business Wire
May-27-16 05:13PM  Uni-Pixels stock plunges after new shares sold at deep discount at MarketWatch
May-26-16 05:11PM  OVASCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements a -29.14%
02:28PM  Why OvaScience Inc (OVAS)s Stock Dropped on Thursday? at Insider Monkey
02:19PM  Biotech's Vicious Secondary Cycle at Bloomberg
11:46AM  Ovascience (OVAS) Stock Drops After Pricing Public Offering
11:33AM  Ovascience May Be Hard-Pressed to Overcome Market Skepticism
11:05AM  OvaScience Prices Secondary Offering
08:35AM  Ovascience's stock plunges after share offering prices at steep discount at MarketWatch
08:00AM  OvaScience Announces Pricing of Public Offering of Common Stock Business Wire
May-25-16 05:28PM  OVASCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +7.00%
04:30PM  OvaScience Announces Proposed Public Offering of Common Stock Business Wire
May-16-16 06:50PM  ETFs with exposure to OvaScience, Inc. : May 16, 2016 +10.04%
May-12-16 11:21AM  OvaScience, Inc. :OVAS-US: Earnings Analysis: Q1, 2016 By the Numbers -7.52%
May-06-16 01:44PM  Edited Transcript of OVAS earnings conference call or presentation 5-May-16 8:30pm GMT -10.00%
May-05-16 04:30PM  OvaScience Inc Earnings Call scheduled for 4:30 pm ET today
04:13PM  OVASCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:11PM  OvaScience reports 1Q loss
04:00PM  OvaScience Reports First Quarter 2016 Financial Results Business Wire
07:07AM  Q1 2016 OvaScience Inc Earnings Release - After Market Close
May-04-16 08:07AM  Arena (ARNA) Q1 Earnings: What's in Store for the Stock? Zacks -10.12%
Apr-28-16 04:00PM  OvaScience to Host First Quarter 2016 Financial Results Conference Call Business Wire -5.22%
Apr-19-16 03:00PM  OvaScience CEO compensation value drops 92 percent in one year at bizjournals.com
Apr-11-16 11:01AM  Ovascience, Inc. (OVAS): Hedge Funds Are Overweight This Biotech Stock at Insider Monkey
Mar-31-16 04:32PM  OVASCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers
07:00AM  OvaScience Announces Senior Management Changes and Appointments Business Wire
Mar-30-16 02:52PM  5 Stocks Insiders Love Right Now at TheStreet
Mar-29-16 06:57AM  Credit Suisse's 12 Contrarian Stock Ideas to Sell Now at TheStreet
OvaScience, Inc., a fertility company, discovers, develops, and commercializes fertility treatment options for women worldwide. The company's patented technology is based on the discovery of egg precursor (EggPC) cells, which are immature egg cells found in the protective outer layer of a woman's own ovaries. It engages in developing and commercializing various fertility treatment options designed to enhance egg health and revolutionize the fertility treatment consisting of AUGMENT to enhance the energy and health of the woman's eggs by using mitochondria from a woman's EggPC cells; OvaTure to produce mature fertilizable eggs from a woman's own EggPC cells without the need for hormone injections; OvaPrime treatment is used to replenish a woman's egg reserve by transferring the EggPCs from woman's own ovaries; and OvaXon for the prevention of inherited human disease and improvement of animal health. The company was formerly known as Ovastem, Inc. and changed its name to OvaScience, Inc. in May 2011. OvaScience, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dipp MichelleChief Executive OfficerJun 01Buy7.00425,0002,975,000962,056Jun 03 04:24 PM
ALDRICH RICHARDDirectorJun 01Buy7.00425,0002,975,000962,056Jun 03 04:25 PM
ALDRICH RICHARDDirectorMay 18Buy7.8620,000157,200537,056May 20 08:07 AM
ALDRICH RICHARDDirectorMay 13Buy7.0616,295115,043477,056May 16 08:25 AM
Dipp MichelleChief Executive OfficerMay 13Buy7.0616,295115,043477,056May 16 08:25 AM
ALDRICH RICHARDDirectorMay 12Buy6.8419,800135,352460,761May 16 08:25 AM
Dipp MichelleChief Executive OfficerMay 12Buy6.8419,800135,352460,761May 16 08:25 AM
ALDRICH RICHARDDirectorMay 11Buy7.6420,000152,800440,961May 13 08:30 AM
Dipp MichelleChief Executive OfficerMay 11Buy7.6420,000152,800440,961May 13 08:30 AM
CHAPMAN PAUL W.D.Chief Operating OfficerMay 10Buy7.373,10022,8473,100May 12 08:03 AM
ALDRICH RICHARDDirectorMay 10Buy7.7219,900153,628420,961May 12 07:59 AM
Dipp MichelleChief Executive OfficerMay 10Buy7.7219,900153,628420,961May 12 07:58 AM